{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:21:54Z","timestamp":1793899314195,"version":"4.8.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.arcmed.2023.102900","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T13:17:41Z","timestamp":1699276661000},"page":"102900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Radiotherapy and Mortality in Pituitary Adenomas"],"prefix":"10.1016","volume":"54","author":[{"given":"Baldomero","family":"Gonz\u00e1lez-Virla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6924-2209","authenticated-orcid":false,"given":"Guadalupe","family":"Vargas-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alfonso","family":"Romero-Gameros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2023.102900_bib0001","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2023.102900_bib0002","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and Treatment of Pituitary Adenomas","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2023.102900_bib0003","unstructured":"ME, Drummond J, Korbonits M. Mark E. Molitch. Prolactinoma Management. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279174\/. (Accessed September 9, 2023)."},{"key":"10.1016\/j.arcmed.2023.102900_bib0004","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: A consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.arcmed.2023.102900_bib0005","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.04.003","article-title":"The risk\/benefit ratio of radiotherapy in pituitary tumors","volume":"33","author":"Minniti","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0007","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2265.2006.02506.x","article-title":"Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas","volume":"64","author":"Minniti","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102900_bib0008","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1530\/EJE-14-0872","article-title":"Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response","volume":"172","author":"Minniti","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1748-717X-6-167","article-title":"Radiation techniques for acromegaly","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13014-016-0710-y","article-title":"Target delineation and optimal radiosurgical dose for pituitary tumors","volume":"11","author":"Minniti","year":"2016","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.arcmed.2023.102900_bib0011","first-page":"476","article-title":"Stereotactic radiation therapy in pituitary adenomas, is it better than conventional radiation therapy?","volume":"13","author":"Gheorghiu","year":"2017","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0012","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.rpor.2014.09.004","article-title":"Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas","volume":"21","author":"Minniti","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.arcmed.2023.102900_bib0013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jocn.2013.03.024","article-title":"Fractionated stereotactic radiosurgery using the Novalis system for the management of pituitary adenomas close to the optic apparatus","volume":"21","author":"Liao","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.arcmed.2023.102900_bib0014","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2013.04.018","article-title":"Evaluation of the clinical usefulness for using verification images during frameless radiosurgery","volume":"108","author":"Gevaert","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-016-2105-1","article-title":"Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus","volume":"128","author":"Iwata","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0016","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11102-007-0004-3","article-title":"Efficacy and safety of CyberKnife radiosurgery for acromegaly","volume":"10","author":"Roberts","year":"2007","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102900_bib0017","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1227\/NEU.0000000000001155","article-title":"Fractionated Stereotactic Radiotherapy for Pituitary Adenomas","volume":"79","author":"Barber","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.arcmed.2023.102900_bib0018","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1042-3680(02)00031-1","article-title":"Radiotherapy and stereotactic radiosurgery for pituitary tumors","volume":"14","author":"Petrovich","year":"2003","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.arcmed.2023.102900_bib0019","doi-asserted-by":"crossref","first-page":"NP10","DOI":"10.1177\/1533034615607113","article-title":"The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma","volume":"15","author":"Puataweepong","year":"2016","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.arcmed.2023.102900_bib0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-019-01955-4","article-title":"Efficacy and safety of fractionated conformal radiation therapy in acromegaly: a long-term follow-up study","volume":"65","author":"Gonzales-Virla","year":"2019","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.arcmed.2023.102900_bib0021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000314299","article-title":"Pituitary Radiotherapy for Cushing's Disease","volume":"92","author":"Losa","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arcmed.2023.102900_bib0022","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11102-011-0348-6","article-title":"Radiotherapy for prolactin-secreting pituitary tumors","volume":"15","author":"Sheplan Olsen","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102900_bib0023","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","article-title":"Growth Hormone and Pituitary Radiotherapy, But Not Serum Insulin-Like Growth Factor-I Concentrations, Predict Excess Mortality in Patients with Acromegaly","volume":"89","author":"Ayuk","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0024","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/jc.2004-1381","article-title":"A Nationwide Survey of Mortality in Acromegaly","volume":"90","author":"Kauppinen-M\u00e4kelin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors Influencing Mortality in Acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0026","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity, and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espa\u00f1ol de Acromegalia, REA)","author":"Mestron","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0027","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly","volume":"94","author":"Sherlock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-12-0084","article-title":"Predictors of morbidity and mortality in acromegaly: an Italian survey","volume":"167","author":"Arosio","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0029","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications, and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1530\/EJE-10-1105","article-title":"Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly","volume":"164","author":"Ronchi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0031","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","article-title":"Determinants of Survival in Treated Acromegaly in a Single Center: Predictive Value of Serial Insulin-Like Growth Factor I Measurements","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0032","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jcem.85.10.6870","article-title":"Hormonal and Metabolic Effects of Radiotherapy in Acromegaly: Long-Term Results in 128 Patients Followed in a Single Center","volume":"85","author":"Barrande","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0033","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.arcmed.2011.01.004","article-title":"Efficacy and Safety of Radiotherapy in Acromegaly","volume":"42","author":"Gonz\u00e1lez","year":"2011","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2023.102900_bib0034","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.radonc.2012.04.024","article-title":"The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone","volume":"104","author":"Sattler","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0036","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2003.12.012","article-title":"Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma","volume":"59","author":"Milker-Zabel","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.arcmed.2023.102900_bib0037","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/EJE-09-1045","article-title":"Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit","volume":"162","author":"Roug","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0038","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","article-title":"Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: A prospective study of 110 patients","volume":"62","author":"Colin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.arcmed.2023.102900_bib0039","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12020-015-0610-1","article-title":"Long-term results of fractionated stereotactic radiotherapy as third-line treatment in acromegaly","volume":"50","author":"Diallo","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.arcmed.2023.102900_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11102-016-0783-5","article-title":"Updates in outcomes of stereotactic radiation therapy in acromegaly","volume":"20","author":"Gheorghiu","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102900_bib0041","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/cancers15051438","article-title":"Efficiency and Safety of CyberKnife Robotic Radiosurgery in the Multimodal Management of Patients with Acromegaly","volume":"15","author":"Romero-Gameros","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.arcmed.2023.102900_bib0042","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.arcmed.2023.102900_bib0043","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-16-0173","article-title":"Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study","volume":"175","author":"Olsson","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0044","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.2014-3697","article-title":"Cerebrovascular Events, Secondary Intracranial Tumors, and Mortality After Radiotherapy for Nonfunctioning Pituitary Adenomas: A Subanalysis from the Dutch National Registry of Growth Hormone Treatment in Adults","volume":"100","author":"van Varsseveld","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0045","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3","article-title":"Incidence of cerebral infarction after radiotherapy for pituitary adenoma","volume":"63","author":"Flickinger","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2023.102900_bib0046","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2002.01570.x","article-title":"Cerebrovascular mortality in patients with pituitary adenoma","volume":"57","author":"Brada","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102900_bib0047","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1210\/jc.2015-1475","article-title":"Excess Mortality in Women and Young Adults with Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/756069","article-title":"Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas","volume":"2015","author":"Vargas","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-017-2530-9","article-title":"Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review","volume":"135","author":"van Westrhenen","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3857\/roj.2016.01683","article-title":"Long-term outcomes of surgery and radiotherapy for secreting and non-secreting pituitary adenoma","volume":"34","author":"Kim","year":"2016","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.arcmed.2023.102900_bib0051","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in Patients Treated for Cushing's Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0052","first-page":"244","article-title":"Pathogenesis of radiation-induced myocardial fibrosis","author":"Fajardo","year":"1973","journal-title":"Lab Invest"},{"key":"10.1016\/j.arcmed.2023.102900_bib0053","first-page":"297","article-title":"Vascular lesions following radiation","author":"Fajardo","year":"1988","journal-title":"Pathol Annu"},{"key":"10.1016\/j.arcmed.2023.102900_bib0054","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in Patients with Pituitary Disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2023.102900_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S1460396913000071","article-title":"Efficacy and safety of external beam radiation therapy in non-functioning pituitary adenomas: a case-control, nested in a cohort study","volume":"13","author":"Vargas","year":"2014","journal-title":"J Radiother Pract"},{"key":"10.1016\/j.arcmed.2023.102900_bib0056","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0057","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Ros\u00e9n","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2023.102900_bib0058","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2023.102900_bib0059","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","article-title":"Hypopituitarism","volume":"388","author":"Higham","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2023.102900_bib0060","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/jc.2014-3787","article-title":"Excess Mortality Associated with Hypopituitarism in Adults: A Meta-Analysis of Observational Studies","volume":"100","author":"Pappachan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0061","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths Among Adult Patients with Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased Mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0062","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"B\u00fclow","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102900_bib0063","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1210\/jc.2002-020526","article-title":"Risk Factors for Cerebrovascular Deaths in Patients Operated and Irradiated for Pituitary Tumors","volume":"87","author":"Erfurth","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102900_bib0064","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.radonc.2009.09.011","article-title":"Radiotherapy for pituitary adenomas: long-term efficacy and toxicity","volume":"93","author":"Erridge","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.arcmed.2023.102900_bib0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-21-0729","article-title":"Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register","volume":"186","author":"Arnard\u00f3ttir","year":"2022","journal-title":"Eur J Endocrinol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:14:38Z","timestamp":1741184078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440923001388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0188440923001388"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102900","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy and Mortality in Pituitary Adenomas","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102900"}}